Rare and Orphan Diseases - Global Neurology Academy

Episodes 33-48 of 60

Transitioning to Adult Care in DMD: Strategies for Long-Term Support
Transitioning to Adult Care in DMD: Strategies for Long-Term Support
NeuroFrontiers
Transitioning to Adult Care in DMD: Strategies for Long-Term Support
- Rosaline Quinlivan
Supporting Adults With DMD: A Guide to Acute and Long-Term Planning
Supporting Adults With DMD: A Guide to Acute and Long-Term Planning
NeuroFrontiers
Supporting Adults With DMD: A Guide to Acute and Long-Term Planning
- Rosaline Quinlivan
The Complexities of DMD: Optimizing Multidisciplinary Care
The Complexities of DMD: Optimizing Multidisciplinary Care
NeuroFrontiers
The Complexities of DMD: Optimizing Multidisciplinary Care
- Rosaline Quinlivan
Investigating Inebilizumab for Generalized Myasthenia Gravis: Results from MINT
Investigating Inebilizumab for Generalized Myasthenia Gravis: Results from MINT
NeuroFrontiers
Investigating Inebilizumab for Generalized Myasthenia Gravis: Results from MINT
- Richard Nowak, MD, MS
Reducing the Burden of gMG with a Novel B-Cell Therapy
Reducing the Burden of gMG with a Novel B-Cell Therapy
NeuroFrontiers
Reducing the Burden of gMG with a Novel B-Cell Therapy
- Richard Nowak, MD, MS
Exploring IGF1R as a New Therapeutic Target in Myasthenia Gravis
Exploring IGF1R as a New Therapeutic Target in Myasthenia Gravis
NeuroFrontiers
Exploring IGF1R as a New Therapeutic Target in Myasthenia Gravis
Advancing CIDP Research: Targeted Therapies, AI Integration, and Immunological Insights
Advancing CIDP Research: Targeted Therapies, AI Integration, and Immunological Insights
Global Neurology Academy
Advancing CIDP Research: Targeted Therapies, AI Integration, and Immunological Insights
- Karissa Gable, MD
mIDH Gliomas Explained: Characteristics and Management Strategies
mIDH Gliomas Explained: Characteristics and Management Strategies
NeuroFrontiers
mIDH Gliomas Explained: Characteristics and Management Strategies
- Jennie Taylor, MD
From Diagnosis to Treatment: Challenges in Glioblastoma Care
From Diagnosis to Treatment: Challenges in Glioblastoma Care
NeuroFrontiers
From Diagnosis to Treatment: Challenges in Glioblastoma Care
- Lauren Schaff, MD
Vorasidenib and mIDH Gliomas: Reviewing the Efficacy Data
Vorasidenib and mIDH Gliomas: Reviewing the Efficacy Data
NeuroFrontiers
Vorasidenib and mIDH Gliomas: Reviewing the Efficacy Data
- Jennie Taylor, MD
Decoding CIDP: Pathogenesis, Diagnosis, and Clinical Clues
Decoding CIDP: Pathogenesis, Diagnosis, and Clinical Clues
Global Neurology Academy
Decoding CIDP: Pathogenesis, Diagnosis, and Clinical Clues
- Hans Katzberg, MD
Understanding CIDP: A Roadmap to Diagnosis
Understanding CIDP: A Roadmap to Diagnosis
Global Neurology Academy
Understanding CIDP: A Roadmap to Diagnosis
- Sami Khella, MD
Evolving Strategies in CIDP Care: Personalized Approaches and Emerging Treatments
Evolving Strategies in CIDP Care: Personalized Approaches and Emerging Treatments
Global Neurology Academy
Evolving Strategies in CIDP Care: Personalized Approaches and Emerging Treatments
- Sami Khella, MD
Investigating Gene Therapy for DMD: The Role of Caregiver-Reporter Scales
Investigating Gene Therapy for DMD: The Role of Caregiver-Reporter Scales
NeuroFrontiers
Investigating Gene Therapy for DMD: The Role of Caregiver-Reporter Scales
- Craig M. McDonald, MD
Next Steps in Gene Therapy Research for Duchenne Muscular Dystrophy
Next Steps in Gene Therapy Research for Duchenne Muscular Dystrophy
NeuroFrontiers
Next Steps in Gene Therapy Research for Duchenne Muscular Dystrophy
- Craig M. McDonald, MD
Diagnosing Duchenne Muscular Dystrophy: Recognizing Signs and Reducing Delays
Diagnosing Duchenne Muscular Dystrophy: Recognizing Signs and Reducing Delays
NeuroFrontiers
Diagnosing Duchenne Muscular Dystrophy: Recognizing Signs and Reducing Delays
- Nancy Kuntz, MD

3/4